We are live on ! Find out more
TLSIW icon

TriSalus Life Sciences Warrant
TLSIW

8 hedge funds and large institutions have $1.08M invested in TriSalus Life Sciences Warrant in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

421% more capital invested

Capital invested by funds: $208K → $1.08M (+$876K)

2.49% more ownership

Funds ownership: 0.71% → 3.2% (+2.5%)

0% more funds holding

Funds holding: 8 → 8 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
8
Holders Change
–
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
GL
Graypoint LLC
New York
+$983K
2
CS
Clear Street
New York
+$119

Top Sellers

1
GS
GTS Securities
New York
-$13.8K
2
HF
HRT Financial
New York
-$8.31K
3
FVWA
Foster Victor Wealth Advisors
South Carolina
-$4.55K
4
WAM
Wolverine Asset Management
Illinois
-$1.01K
Name Holding Trade Value Shares
Change 		Change in
Stake
GL
1
Graypoint LLC
New York
$910K +$983K +827,590 New
VI
2
Vestcor Inc
New Brunswick, Canada
$89K – – –
ACM
3
Alpha Capital Management
Texas
$24.4K – – –
HF
4
HRT Financial
New York
$23K -$8.31K -6,997 -25%
FVWA
5
Foster Victor Wealth Advisors
South Carolina
$22.2K -$4.55K -3,830 -17%
WAM
6
Wolverine Asset Management
Illinois
$15.3K -$1.01K -851 -6%
CS
7
Clear Street
New York
$110 +$119 +100 New
TRCT
8
Tower Research Capital (TRC)
New York
$46 – – –
CAC
9
Cowen and Company
New York
– -$20.6K -20,369 Closed
GS
10
GTS Securities
New York
– -$13.8K -13,132 Closed

TLSIW Hedge Fund Activity: Q4 2024 in Review

8 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences Warrant (TLSIW) for Q4 2024, worth a combined $1.08M — up 421% from $208K a quarter earlier.

Fund positioning in TLSIW was balanced in Q4 2024: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 3 trimmed.

The largest buyer was Graypoint LLC, opening a new position worth an estimated $983K. The largest seller was GTS Securities, exiting entirely with an estimated $13.8K sold.

  • 8 institutional investors held TriSalus Life Sciences Warrant (TLSIW) as of Q4 2024, unchanged from Q3 2024.
  • Funds reported $1.08M of TriSalus Life Sciences Warrant stock for Q4 2024, up 421% quarter-over-quarter.
  • 2 funds opened new TriSalus Life Sciences Warrant positions in Q4 2024 and 2 closed out, a net change of 0 holders.
  • The largest TriSalus Life Sciences Warrant buyer in Q4 2024 was Graypoint LLC, an estimated $983K added.
  • The largest TriSalus Life Sciences Warrant seller in Q4 2024 was GTS Securities, an estimated $13.8K sold.

Based on aggregated 13F filings for Q4 2024.